Spinal Cord Injury and Related Clinical Trials

Young-Hoon Kim1, Kee-Yong Ha1, Sang-Il Kim1

  • 1Department of Orthopaedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Insights

Spinal cord injury (SCI) treatment focuses on reducing secondary damage through neuroprotective and neuroregenerative strategies. Cell therapy shows promise, but a gold standard treatment for SCI remains elusive.

Area of Science:

  • * Neuroscience
  • * Regenerative Medicine
  • * Clinical Trials

Background:

  • * Spinal cord injury (SCI) results in severe, often incurable, long-term complications.
  • * Current SCI treatment lacks a definitive, evidence-based gold standard.
  • * Secondary damage following the initial injury is a critical therapeutic target.

Purpose of the Study:

  • * To review the pathophysiology of spinal cord injury.
  • * To introduce current therapeutic candidates for SCI treatment.
  • * To discuss advancements in neuroprotective and neuroregenerative strategies.

Main Methods:

  • * Literature review of SCI pathophysiology.
  • * Analysis of neuroprotective and neuroregenerative therapeutic concepts.
  • * Examination of cell therapy and transplantation research.

Main Results:

  • * Neuroprotection aims to mitigate secondary injury mechanisms.
  • * Neuroregeneration seeks to enhance intrinsic repair processes.
  • * Cell-based therapies are under active investigation.

Conclusions:

  • * Effective SCI treatment requires addressing secondary damage.
  • * Both neuroprotective and neuroregenerative approaches are crucial.
  • * Ongoing research, including cell therapy, offers potential future treatments for SCI.